health

HHS, drug firm partner to develop new antibiotics

NEWS IN BRIEF — Posted June 3, 2013

Print  |   Email  |   Respond  |   Reprints  |   Like Facebook  |   Share Twitter  |   Tweet Linkedin

In a first-of-its-kind collaboration, a leading pharmaceutical company is teaming up with the U.S. government to develop new antibiotics to combat bioterrorism threats and growing resistance to the drugs.

The partnership between GlaxoSmithKline and the Biomedical Advanced Research and Development Authority, which is in the Dept. of Health and Human Services, was announced May 21.

As part of the public-private agreement, HHS will give GSK $40 million for the first 18 months. The company could take in a total of $200 million if the agreement is renewed over five years, GSK said. The partnership provides GSK the flexibility to move funding around its antibacterial portfolio, rather than focusing on just one drug candidate, the manufacturer said.

A joint oversight committee will monitor the manufacturer’s progress, make decisions on the allocation of funds and decide on the addition or removal of drug candidates from the portfolio (link).

The collaboration comes as many drug companies are withdrawing from antibacterial research and development, due, in part, to the scientific challenges of manufacturing a novel antibacterial and a lower return on investment, GSK said. When new antibacterial drugs are developed, physicians use them sparingly, compared with drugs for chronic diseases that patients often use for the rest of their lives, medical experts say.

Back to top


ADVERTISEMENT

ADVERTISE HERE


Featured
Read story

Confronting bias against obese patients

Medical educators are starting to raise awareness about how weight-related stigma can impair patient-physician communication and the treatment of obesity. Read story


Read story

Goodbye

American Medical News is ceasing publication after 55 years of serving physicians by keeping them informed of their rapidly changing profession. Read story


Read story

Policing medical practice employees after work

Doctors can try to regulate staff actions outside the office, but they must watch what they try to stamp out and how they do it. Read story


Read story

Diabetes prevention: Set on a course for lifestyle change

The YMCA's evidence-based program is helping prediabetic patients eat right, get active and lose weight. Read story


Read story

Medicaid's muddled preventive care picture

The health system reform law promises no-cost coverage of a lengthy list of screenings and other prevention services, but some beneficiaries still might miss out. Read story


Read story

How to get tax breaks for your medical practice

Federal, state and local governments offer doctors incentives because practices are recognized as economic engines. But physicians must know how and where to find them. Read story


Read story

Advance pay ACOs: A down payment on Medicare's future

Accountable care organizations that pay doctors up-front bring practice improvements, but it's unclear yet if program actuaries will see a return on investment. Read story


Read story

Physician liability: Your team, your legal risk

When health care team members drop the ball, it's often doctors who end up in court. How can physicians improve such care and avoid risks? Read story